Current Neuro-Oncology
Volume
28 Number 11
20 April 2026
Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 11, 20 April
Cleary RT, Fu Y, Giles D, Yuan J, Moniz Garcia DP, Palmer D, Han
RH, Woodiwiss T, Yang AB, Mathios D, Chen H, Kim AH.
Laser
Interstitial Thermal Therapy Enhances Bidirectional Blood-Brain
Barrier Permeability in Glioblastoma.
Neuro
Oncol. 2026 Apr 13:noag080. doi:
10.1093/neuonc/noag080. PMID:
41981754. ˍ
Rüssli S, Descombes C, Terrapon APR, Hinsberger M, Maragkou
T, Zubak I, Häni L, Schucht P, Raabe A, Goldberg J.
Higher
perioperative dexamethasone exposure is associated with shorter
survival in glioblastoma.
Neurooncol
Adv. 2026 Apr 13;8(1):vdag099. doi:
10.1093/noajnl/vdag099. PMID:
42100168. ˍ
Eschen JT, Jensen LL, Hausmann D, Lind ANR, Lukacova S,
Weischenfeldt J, Lassen U, Westphal M, Winkler F, Simonsen U,
Korshoej AR.
SENIPERA Phase 0/1
randomized window-of-opportunity clinical trial of SENIcapoc and
PERAmpanel mono- and combination therapy of newly diagnosed
glioblastoma: a trial protocol.
BMC
Cancer. 2026 Apr 14;26(1):667. doi:
10.1186/s12885-026-15784-y. PMID:
41981510. Trial
registration ID: EU-CT: 2025–522605-37–00.
ˍ
Lee JS, Lee JI, Shin HJ, Choi JW.
Gamma
knife radiosurgery in pediatric neuro-oncology: histology-specific
outcomes and age-adapted procedural strategies.
Childs
Nerv Syst. 2026 Apr 14;42(1):157. doi:
10.1007/s00381-026-07205-z. PMID:
41979696. ˍ
Wang J, Xing Y, Zhao X, Cao Y, Zheng N, Wang W, Zhou L.
A
case report about extracranial skeletal metastases in pediatric
diffuse midline glioma, H3 K27-altered.
Childs
Nerv Syst. 2026 Apr 14;42(1):158. doi:
10.1007/s00381-026-07249-1. PMID:
41979668˰ ˍ
Wen PY, Berry DA, Buxton MB, Colman H, de Groot J, Lim M,
Mellinghoff I, Perry JR, Weller M, Blondin NA, Butt OH, Damek DM,
de la Fuente MI, Drappatz J, Dunbar E, Giglio P, Hyddmark EV,
Iwamoto F, Jaeckle KA, Kim L, Kling HM, Lee EQ, Mantica M,
Mikkelsen T, Nabors B, Newton HB, Olson JJ, Schiff D, Walbert T,
Weathers SP, Cloughesy T, Lassman AB; GBM AGILE Regorafenib Study
Group.
Evaluation of Regorafenib in
Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III
Bayesian Randomized Platform Trial.
J
Clin Oncol. 2026 Apr 14:JCO2501137. doi:
10.1200/JCO-25-01137. PMID:
41980234. Trial
registration ID: NCT03970447. ˍ
Cordell EC, Mansour M, Pantel AR, Schubert E, Nabavizadeh A, Mohan
S, Maloney E, Prior T, Angeloni N, Blessing C, Frangos S, Coghlan
L, Wileyto EP, O'Rourke DM, Brem S, Desai AS, Bagley SJ.
A
phase 2 study of niraparib concomitant with tumor treating fields
in patients with recurrent grade 4 glioma.
Neurooncol
Adv. 2026 Apr 20;8(1):vdag076. doi:
10.1093/noajnl/vdag076. PMID:
42058764. Trial
registration ID: NCT04221503. ˍ
Omachi T, Hayashi M, Atsumi N, Oonaka C, Matsuno R, Emori K, Urabe
K, Yamazoe T, Ikeda Y, Tsuta K, Nonaka M, Kaneko K.
Synergistic
antitumor effect of temozolomide and perampanel in pediatric
glioma: a case report and in vitro validation using
patient-derived glioma sphere cells.
Acta
Neuropathol Commun. 2026 Apr 16;14(1):117. doi:
10.1186/s40478-026-02297-9. PMID:
41992293. ˍ
Telkhade T, Rathored J, Budhbaware T, Mulugeta K, Iratwar S.
Prolonged survival in pediatric
diffuse intrinsic pontine glioma following intensity-modulated
radiation therapy: a case report.
J
Med Case Rep. 2026 Apr 20;20(1):300. doi:
10.1186/s13256-026-06026-7. PMID:
42010728. ˍ